
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
G9a promotes cell proliferation and suppresses autophagy in gastric cancer by directly activating mTOR
Chao Yin, Xiaoxue Ke, Rui Zhang, et al.
The FASEB Journal (2019) Vol. 33, Iss. 12, pp. 14036-14050
Open Access | Times Cited: 43
Chao Yin, Xiaoxue Ke, Rui Zhang, et al.
The FASEB Journal (2019) Vol. 33, Iss. 12, pp. 14036-14050
Open Access | Times Cited: 43
Showing 1-25 of 43 citing articles:
Post‐translational modifications of histones: Mechanisms, biological functions, and therapeutic targets
Ruiqi Liu, Jiajun Wu, H. Henry Guo, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 99
Ruiqi Liu, Jiajun Wu, H. Henry Guo, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 99
Epigenetic and post-translational modifications in autophagy: biological functions and therapeutic targets
Feng Shu, Xiao Han, Qiu-Nuo Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 72
Feng Shu, Xiao Han, Qiu-Nuo Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 72
Histone modifications in epigenetic regulation of cancer: Perspectives and achieved progress
Маргарита Е. Неганова, С. Г. Клочков, Yulia Aleksandrova, et al.
Seminars in Cancer Biology (2020) Vol. 83, pp. 452-471
Closed Access | Times Cited: 124
Маргарита Е. Неганова, С. Г. Клочков, Yulia Aleksandrova, et al.
Seminars in Cancer Biology (2020) Vol. 83, pp. 452-471
Closed Access | Times Cited: 124
S‐adenosylmethionine: A metabolite critical to the regulation of autophagy
Yang Ouyang, Qi Wu, Juanjuan Li, et al.
Cell Proliferation (2020) Vol. 53, Iss. 11
Open Access | Times Cited: 107
Yang Ouyang, Qi Wu, Juanjuan Li, et al.
Cell Proliferation (2020) Vol. 53, Iss. 11
Open Access | Times Cited: 107
Progress in Natural Compounds/siRNA Co-delivery Employing Nanovehicles for Cancer Therapy
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, et al.
ACS Combinatorial Science (2020) Vol. 22, Iss. 12, pp. 669-700
Open Access | Times Cited: 84
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, et al.
ACS Combinatorial Science (2020) Vol. 22, Iss. 12, pp. 669-700
Open Access | Times Cited: 84
Cinnamaldehyde induces autophagy-mediated cell death through ER stress and epigenetic modification in gastric cancer cells
Tae Woo Kim
Acta Pharmacologica Sinica (2021) Vol. 43, Iss. 3, pp. 712-723
Open Access | Times Cited: 57
Tae Woo Kim
Acta Pharmacologica Sinica (2021) Vol. 43, Iss. 3, pp. 712-723
Open Access | Times Cited: 57
Therapeutic strategies of dual-target small molecules to overcome drug resistance in cancer therapy
Jing Ye, Junhao Wu, Bo Liu
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188866-188866
Closed Access | Times Cited: 25
Jing Ye, Junhao Wu, Bo Liu
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188866-188866
Closed Access | Times Cited: 25
MicroRNA-mediated autophagy regulation in cancer therapy: The role in chemoresistance/chemosensitivity
Milad Ashrafizadeh, Ali Zarrabi, Sima Orouei, et al.
European Journal of Pharmacology (2020) Vol. 892, pp. 173660-173660
Closed Access | Times Cited: 68
Milad Ashrafizadeh, Ali Zarrabi, Sima Orouei, et al.
European Journal of Pharmacology (2020) Vol. 892, pp. 173660-173660
Closed Access | Times Cited: 68
Dehydrodiisoeugenol inhibits colorectal cancer growth by endoplasmic reticulum stress-induced autophagic pathways
Changhong Li, Kui Zhang, Guangzhao Pan, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 46
Changhong Li, Kui Zhang, Guangzhao Pan, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 46
Epigenetic Mechanisms in Gastric Cancer: Potential New Therapeutic Opportunities
Matteo Canale, Andrea Casadei‐Gardini, Paola Ulivi, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5500-5500
Open Access | Times Cited: 43
Matteo Canale, Andrea Casadei‐Gardini, Paola Ulivi, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5500-5500
Open Access | Times Cited: 43
Insight into the multi-faceted role of the SUV family of H3K9 methyltransferases in carcinogenesis and cancer progression
N. Saha, Andrew G. Muntean
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1875, Iss. 1, pp. 188498-188498
Open Access | Times Cited: 43
N. Saha, Andrew G. Muntean
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1875, Iss. 1, pp. 188498-188498
Open Access | Times Cited: 43
Structure, Activity, and Function of the Protein Lysine Methyltransferase G9a
Coralie Poulard, Lara Malik Noureddine, Ludivine Pruvost, et al.
Life (2021) Vol. 11, Iss. 10, pp. 1082-1082
Open Access | Times Cited: 35
Coralie Poulard, Lara Malik Noureddine, Ludivine Pruvost, et al.
Life (2021) Vol. 11, Iss. 10, pp. 1082-1082
Open Access | Times Cited: 35
G9a Inhibition Enhances Checkpoint Inhibitor Blockade Response in Melanoma
Gregory M. Kelly, Fares Al‐Ejeh, Robert McCuaig, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 9, pp. 2624-2635
Open Access | Times Cited: 32
Gregory M. Kelly, Fares Al‐Ejeh, Robert McCuaig, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 9, pp. 2624-2635
Open Access | Times Cited: 32
G9a/GLP targeting in MM promotes autophagy-associated apoptosis and boosts proteasome inhibitor–mediated cell death
Eva De Smedt, Julie Devin, Catharina Muylaert, et al.
Blood Advances (2021) Vol. 5, Iss. 9, pp. 2325-2338
Open Access | Times Cited: 27
Eva De Smedt, Julie Devin, Catharina Muylaert, et al.
Blood Advances (2021) Vol. 5, Iss. 9, pp. 2325-2338
Open Access | Times Cited: 27
Research progress of dual inhibitors targeting crosstalk between histone epigenetic modulators for cancer therapy
Ying‐Chao Duan, Shaojie Zhang, Xiaojing Shi, et al.
European Journal of Medicinal Chemistry (2021) Vol. 222, pp. 113588-113588
Closed Access | Times Cited: 27
Ying‐Chao Duan, Shaojie Zhang, Xiaojing Shi, et al.
European Journal of Medicinal Chemistry (2021) Vol. 222, pp. 113588-113588
Closed Access | Times Cited: 27
Novel insights into histone lysine methyltransferases in cancer therapy: From epigenetic regulation to selective drugs
Qi-Li Liao, Jie Yang, Shengfang Ge, et al.
Journal of Pharmaceutical Analysis (2022) Vol. 13, Iss. 2, pp. 127-141
Open Access | Times Cited: 20
Qi-Li Liao, Jie Yang, Shengfang Ge, et al.
Journal of Pharmaceutical Analysis (2022) Vol. 13, Iss. 2, pp. 127-141
Open Access | Times Cited: 20
Chromatin and noncoding RNA-mediated mechanisms of gastric tumorigenesis
Adrian Kwan Ho Loe, Lexin Zhu, Tae-Hee Kim
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 1, pp. 22-31
Open Access | Times Cited: 12
Adrian Kwan Ho Loe, Lexin Zhu, Tae-Hee Kim
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 1, pp. 22-31
Open Access | Times Cited: 12
Selective histone methyltransferase G9a inhibition reduces metastatic development of Ewing sarcoma through the epigenetic regulation of NEU1
Daniel J. García-Domínguez, Nabil Hajji, Roser López‐Alemany, et al.
Oncogene (2022) Vol. 41, Iss. 18, pp. 2638-2650
Open Access | Times Cited: 18
Daniel J. García-Domínguez, Nabil Hajji, Roser López‐Alemany, et al.
Oncogene (2022) Vol. 41, Iss. 18, pp. 2638-2650
Open Access | Times Cited: 18
G9a in Cancer: Mechanisms, Therapeutic Advancements, and Clinical Implications
Yuchao Ni, Mingchen Shi, Liangliang Liu, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2175-2175
Open Access | Times Cited: 3
Yuchao Ni, Mingchen Shi, Liangliang Liu, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2175-2175
Open Access | Times Cited: 3
VEGF knockdown enhances radiosensitivity of nasopharyngeal carcinoma by inhibiting autophagy through the activation of mTOR pathway
Li Chen, Guoxiang Lin, Kai-Hua Chen, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 26
Li Chen, Guoxiang Lin, Kai-Hua Chen, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 26
The mTORC1–G9a–H3K9me2 axis negatively regulates autophagy in fatty acid–induced hepatocellular lipotoxicity
Arjamand Mushtaq, Nissar Ul Ashraf, Mohammad Altaf
Journal of Biological Chemistry (2023) Vol. 299, Iss. 3, pp. 102937-102937
Open Access | Times Cited: 7
Arjamand Mushtaq, Nissar Ul Ashraf, Mohammad Altaf
Journal of Biological Chemistry (2023) Vol. 299, Iss. 3, pp. 102937-102937
Open Access | Times Cited: 7
MESP2 binds competitively to TCF4 to suppress gastric cancer progression by regulating the SKP2/p27 axis
Lingjun Ge, Gaichao Zhao, Chao Lan, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Lingjun Ge, Gaichao Zhao, Chao Lan, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Euchromatic Histone Lysine Methyltransferase 2 Inhibition Enhances Carfilzomib Sensitivity and Overcomes Drug Resistance in Multiple Myeloma Cell Lines
Elisabetta Mereu, Damiano Abbo, Tina Paradžik, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2199-2199
Open Access | Times Cited: 7
Elisabetta Mereu, Damiano Abbo, Tina Paradžik, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2199-2199
Open Access | Times Cited: 7
Thymoquinone Is a Multitarget Single Epidrug That Inhibits the UHRF1 Protein Complex
Omeima Abdullah, Ziad Omran, Salman Hosawi, et al.
Genes (2021) Vol. 12, Iss. 5, pp. 622-622
Open Access | Times Cited: 16
Omeima Abdullah, Ziad Omran, Salman Hosawi, et al.
Genes (2021) Vol. 12, Iss. 5, pp. 622-622
Open Access | Times Cited: 16
Histone and DNA Methylation as Epigenetic Regulators of DNA Damage Repair in Gastric Cancer and Emerging Therapeutic Opportunities
Katia De Marco, Paola Sanese, Cristiano Simone, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 4976-4976
Open Access | Times Cited: 6
Katia De Marco, Paola Sanese, Cristiano Simone, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 4976-4976
Open Access | Times Cited: 6